API moves to buy SILK Laser for $169M

business acquisitions handshake
Board of 140-plus non-surgical aesthetics clinic chain supports deal Australian Pharmaceutical Industries (API) has entered into an transaction process agreement with non-surgical aesthetics outfit SILK Laser Australia to acquire 100% of its outstanding shares $3.15 per share. Wesfarmers, of which API is now a wholly-owned subsidiary, has entered a transaction process deed with SILK Laser

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Aussie elected to FIP Board of Pharmaceutical Practice
Next GP grants no cure all: Guild